Differentiation between descending thoracic aortic diseases using machine learning and plasma proteomic signatures

Amanda Momenzadeh1,2,3, Simion Kreimer2,3, Dongchuan Guo4

  • 1Department of Computational Biomedicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.

Clinical Proteomics
|June 2, 2024
PubMed
Summary

Machine learning can identify subtle plasma proteomic differences between descending thoracic aortic aneurysm (DTAA) and type B dissection (Type B) patients. This approach helps prioritize proteins involved in immune response and coagulation for potential diagnostic biomarkers.

Related Concept Videos